Clinical TrialsSearch results
Number of results: 553
Other
- PhaseII trial of erlotinib for elderly patients with advanced or recurrent non-small cell lung cancer
- Non-small cell lung cancer
- Keio University School of Medicine Division of Pulmonary Medicine
- 2009-04-11
Other
- Phase III trial of upfront debulking surgery vs. neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers (JCOG0602, OV-NACTC-P3)
- stage III/IV mullerian carcinomas such as ovarian, tubal and peritoneal carcinomas
- Japan Clinical Oncology Group(JCOG)
- 2006-11-17
Other
- Phase III trial of neoadjuvant chemotherapy followed by surgery versus surgery alone for bulky stage I/II cervical cancer: Japan Clinical Oncology Group trial (JCOG0102)
- Patients with cervical cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Other
- Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
- Patients with Metatatic Breast Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose Cytarabine With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study)
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2005-09-12
Other
- Phase III Randomized Study of Imatinib therapy in chornic phase chronic myeloid leukemia comparing standard dose-escalation with progressive dose-escalation (JALSG CML207study)
- Previously untreated Chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2007-09-15
Other
- Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
- The Tokyo cooperative oncology group
- 2007-04-01
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Exemestane Versus Anastrozole Versus Tamoxifen in Hormone-Responsive Postmenopausal Breast Cancer Patients
- hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 04 executive committee
- 2005-08-12